Although MS occurs more commonly in adults, recognizing MS in children remains critical for improving long-term outcomes6

 

Patients with pediatric-onset MS almost always present with a relapsing-remitting course14
Impact Overview

MS follows a damaging and progressive course
Relapse rates in children during the first 6 years of disease are more than 2x higher than in adults15
   
The number of brain lesions in children at disease onset are predictors of clinical disability and outcome16
   
Relapses are more frequent and severe than in adults4,17

 

     – 2 to 3 times more frequent18

 

    – Frequently categorized as severe4

 

To prevent clinical relapse and CNS injury in children, an early and accurate diagnosis is critical.17

CNS=central nervous system.

Pediatric patients with MS reach disability milestones 7 to 12 years earlier than adults.19


The Expanded Disability Status Scale (EDSS) is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death due to MS) in half-point increments, most often administered by a neurologist.2

Expanded Disability Status Scale20

 

Physical







 
 
Childhood is a critical period for brain development22
   
MS-related brain lesions in children may severely impact brain development, resulting in reduced brain volume and skull size22
   
Children with MS experience disability milestones and irreversible disability earlier than adults.17,19
Cognitive

 
CNS damage in children leads to impaired cognition

30% to 50% of patients have reported cognitive impairment4,16
   
Increased difficulty in learning10
   
Decrease in school grades
   

 

Most frequent areas of impairment16
Complex attention

Executive function

Fine motor and information-processing speed

Verbal ability

Visuospatial memory
Children with MS experience brain volume loss during a phase of expected brain growth23
Emotional

MS disrupts the lives of children and teens by impacting interactions with school, friendships, hobbies and family24





 
Creates continuous challenges
   
Increased school absences25
   
Limitations to fully joining peer-related activities24
   
Routine doctors' appointments, periodic clinical exams and tests24

 

   – Ongoing treatments (and side effects)



 

 

Causes emotional stress from living with a chronic illness
   
Can lead to frustration, anger, and withdrawal24
   
Based on parent-reported symptoms, 29% of children with MS experienced depression and 39% experienced behavioral problems16

 

   – Suicide may be a risk factor for teens and adolescents living with MS24
   
The burden of illness in children begins early. Recognize the symptoms of MS and partner with a neurology colleague today.

 

Follow the clues in your pediactric patients with this downloadable questionnaire about MS symptoms
Identifying MS early can make all the difference. Partner with a multidisciplinary care team, including a neurologist or pediatric neurologist, upon early suspicion of MS in your young patients. 

 

+
References:
 
1. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 2009;15(5):627-631. 2. National Multiple Sclerosis Society. https://www.nationalmssociety.org/. Published August 27, 2018. Accessed April 19, 2019. 3. Belman AL, Krupp LB, Olsen CS, et al. Characteristics of children and adolescents with multiple sclerosis. Pediatrics. 2016;138(1):e20160120. 4. Ghezzi A, Baroncini D, Zaffaroni M, Comi G. Pediatric versus adult MS: similar or different? Mult Scler Demyelinating Disord. Published online May 7, 2017. doi:10.1186/s40893-017-0022-6. 5. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007;356(25):2603-2613. 6. Pena JA, Lotze TE. Pediatric multiple sclerosis: current concepts and consensus definitions. Autoimmune Dis. 2013;2013:673947. 7. Alroughani R, Boyko A. Pediatric multiple sclerosis: a review. BMC Neurol. 2018;18(1):27. doi:10.1186/s12883-018-1026-3. 8. Lulu S, Graves J, Waubant E. Menarche increases relapse risk in pediatric multiple sclerosis. Mult Scler. 2016;22(2):193-200. 9. Chabas D, Green AJ, Waubant E. Pediatric multiple sclerosis. NeuroRx. 2006;3(2):264-275. 10. Venkateswaran S, Banwell B. Pediatric multiple sclerosis. Neurologist. 2010;16(2):92-105. 11. Mellen Center Approach: Pediatric Onset Multiple Sclerosis. Cleveland Clinic. https://my.clevelandclinic.org/-/scassets/files/org/neurological/multipl.... Accessed April 19, 2019. 12. Ghezzi A. Pediatric multiple sclerosis: epidemiology, clinical aspects, diagnosis and treatment. Neurodegener Dis Manag. 2017;7(6s):23-25. 13. Pediatric Multiple Sclerosis. Cleveland Clinic. https://my.clevelandclinic.org/ccf/media/files/Multiple_sclerosis_center.... Accessed April 19, 2019. 14. Jancic J, Nikolic B, Ivancevic N, et al. Multiple sclerosis in pediatrics: current concepts and treatment options. Neurol Ther. 2016;5(2):131-143. 15. Chitnis T, Arnold DL, Banwell B, et al. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis. N Engl J Med. 2018;379(11):1017-1027. 16. Amato MP, Krupp LB, Charvet LE, et al. Pediatric multiple sclerosis: cognition and mood. Neurology. 2016;87(suppl 2):S82-S87. 17. Waldman A, Ness J, Pohl D, Chitnis T. Pediatric multiple sclerosis: clinical features and outcome. Neurology. 2016;87(9 suppl 2):S74-S81. 18. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009;66(1):54-59. 19. Harding KE, Liang K, Cossburn MD, et al. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2013;84(2):141-147. 20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-1452. 21. Aubert-Broche B, Fonov V, Narayanan S, et al. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology. 2014;83(23):2140-2146. 22. Kerbrat A, Aubert-Broche B, Fonov V, et al. Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology. 2012;78(3):194-201. 23. Nobis K, Bartels F, Anlar B, et al. Pediatric multiple sclerosis is associated with brain growth failure. Neuropediatrics. 2006;47. doi: 10.1055/s-0036-1583721. 24. MacAllister WS, Boyd JR, Holland NJ, et al. Neurology. 2007;68(16 suppl 2):S66-69. 25. Banwell B, Bar-Or A, Giovannoni G, Dale RC, Tardieu M. Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol. 2011;7(2):109-122.



 

Rate this content: 
Durchschnitt (1 Bewertung)
×

Ask Speakers

×

Medical Information Request